USPTO serial 90534109
VYANTBIO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 25, 2022
- Examiner
- SNAPP, TINA LOUISE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with VYANTBIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
CHERRY HILL, NJ
CHERRY HILL, NJ
Eden Prairie, MN
Eden Prairie, MN
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Daniel A. Rosenberg
Daniel A. Rosenberg TAFT LAW FIRM2200 IDS CENTER, 80 S. 8TH ST.MINNEAPOLIS, MN 55402UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Cells for medical or clinical use; stem cells for medical purposes | ACTIVE | Oct 27, 2021 |
| 042 | Research and development services in the field of biological tissue and organoid, namely, miniature or simplified biological organs; research and development services in the field of healthy and diseased tissue and organoids for use in scientific and medical research and drug development; custom design and development of biochemical assays; medical, pharmacological, and biological assay services, namely, custom design and development of biochemical assays; custom design and development of medical, pharmacological, and biological assays for drug development, screening, testing and evaluation; technical research and consultation in the field of in vivo and in vitro pharmacology, efficacy, and safety studies and testing including in vivo Investigational New Drug (IND) investigations; technical research and consultation in the field of in vivo and in vitro pharmacology, efficacy, and safety studies and testing including in vivo Investigational New Drug (IND) investigations for drugs, nutraceuticals, vitamins, and natural products; computer modeling services, namely, analysis and modeling of tissue and organoid performance and characteristics in response to medical and scientific treatments and effects | ACTIVE | Oct 27, 2021 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by VYANT BIO, INC.
- Other trademarks owned by VYANT BIO, INC.
- Other trademarks owned by StemoniX, Inc.
- Other trademarks owned by StemoniX, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named VYANTBIO
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 25, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 21, 2021 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Dec 18, 2021 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Dec 1, 2021 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Nov 30, 2021 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Nov 17, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 27, 2021 | IUAF | USE AMENDMENT FILED | — |
| Oct 27, 2021 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Sep 21, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 27, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 27, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 7, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 19, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 18, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 17, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 17, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 16, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 16, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 16, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 9, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 21, 2021 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| May 20, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |